| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C25H41NO9.2BrH.3H2O |
| Molecular Weight | 1215.058 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 30 / 30 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.Br.Br.CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@@H]1[C@@]3([C@@H]5C[C@@]6(O)[C@H](O)[C@@H]5[C@]4(O)[C@@H](O)[C@@H]6OC)[C@H](C[C@H]2O)OC.CCN7C[C@@]8(COC)[C@H]9[C@@H](OC)[C@H]%10[C@@H]7[C@@]9([C@@H]%11C[C@@]%12(O)[C@H](O)[C@@H]%11[C@]%10(O)[C@@H](O)[C@@H]%12OC)[C@H](C[C@H]8O)OC
InChI
InChIKey=VEGQBBZZXIDUOZ-JKOLYEEPSA-N
InChI=1S/2C25H41NO9.2BrH.3H2O/c2*1-6-26-9-22(10-32-2)12(27)7-13(33-3)24-11-8-23(30)19(28)14(11)25(31,20(29)21(23)35-5)15(18(24)26)16(34-4)17(22)24;;;;;/h2*11-21,27-31H,6-10H2,1-5H3;2*1H;3*1H2/t2*11-,12-,13+,14-,15+,16+,17-,18-,19-,20+,21+,22+,23-,24+,25-;;;;;/m11...../s1
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
MOL RATIO
2 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C25H41NO9 |
| Molecular Weight | 499.5943 |
| Charge | 0 |
| Count |
MOL RATIO
2 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 15 / 15 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
MOL RATIO
3 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|